Background: IgE sensitization is a prerequisite for the development of allergic symptoms. The investigation of factors influencing the development of IgE is therefore crucial for understanding the onset of allergic diseases. Methods: This epidemiological study investigated personal, intrinsic, and lifestyle factors in a nonselected cohort of 501 Austrian adolescents (aged 12-21 years). IgE levels to 112 allergen molecules were analyzed in the serum of participants using the ImmunoCAP ISAC®. Allergic sensitization, IgE levels to single allergens, and ISAC score sums were correlated with results obtained from a questionnaire. Results: In this adolescent cohort, male participants showed a higher sensitization frequency (56.8%) compared to females (50.9%) and significantly increased IgE levels to profilins. Underweight subjects demonstrated a stronger IgE sensitization. Family size inversely correlated with IgE levels to PR-10 allergens, and predominately paternal allergies were a predictive factor for IgE sensitization in the children. Vaccination, breastfeeding, and delivery mode showed no influence, while a highly protective effect was observed for growing up on a farm. Of all of the investigated lifestyle factors, only smoking significantly influenced the risk for IgE development. Participants with moderate frequencies of colds showed increased sensitization levels. Conclusion: A hereditary predisposition and lifestyle factors such as a farming environment, smoking, family size, body weight, or frequency of colds significantly influenced the development of allergen-specific IgE in this cohort of adolescents.

The incidence of IgE sensitization and allergic diseases has been on the rise in the past decades [1]. Countries favoring a “westernized” lifestyle seem to be especially affected, and factors influencing this development are widely discussed in the literature [2]. Besides anamnesis, IgE sensitization represents a hallmark of allergy diagnosis using either extract-based tests or single, purified allergen molecules. The testing of defined allergen components allows a more precise diagnosis regarding symptom severity and discrimination of IgE cross-reactivity versus cosensitization [3]. In addition, multiplex technologies permit the simultaneous testing of allergen panels using minute amounts of serum. The onset of IgE sensitization has been linked to several factors, and the influences of a hereditary predisposition and a farming environment were identified in a number of studies [4,5,6,7]. The impacts of lifestyle on allergic disease is, however, frequently controversially discussed [1]. Therefore, epidemiologic investigations of well-defined study cohorts are needed to shed light on the development of allergic diseases and potentially contribute to the identification of preventive measures.

Serum samples from a cohort of 501 nonselected Austrian adolescents (aged 12-21 years) were analyzed for IgE to 112 single components using the ImmunoCAP ISAC® [8]. Personal data and lifestyle information were assessed by a questionnaire and correlated with sensitization data. In order to reflect the number of different sensitizations as well as IgE levels, we established the ISAC score sum for each individual, ranging from 0 (nonsensitized) to 39 (high IgE levels in all investigated allergen source families). Detailed information on study design, IgE sensitization, lifestyle data, and statistical analysis can be found in online supplementary Methods, Table E1, and Figure E1 (for all online suppl. material, see www.karger.com/doi/10.1159/000475499).

Personal Data

In this cohort of 501 adolescents, a general sensitization rate of 53.5% was detected by means of ImmunoCAP ISAC® analysis [8]. Additional data regarding the study population is displayed in Figure 1a. A higher sensitization prevalence among males (56.8%) compared to females (50.9%), as well as a higher mean ISAC score sum (4.1 for male vs. 3.4 for female) was detected, but was not statistically significant. Significantly higher ISAC standardized units (ISU) were found for profilins Mer a 1, Bet v 2, and Hev b 8 among male participants (p < 0.032). No correlation of age and body height with IgE sensitization, ISAC score sum, or ISU levels to single allergens was observed. Only the height of girls correlated weakly, but significantly, with the ISAC score sum (p = 0.020, rho = 0.14). Negative correlations were identified between BMI-for-age percentiles and IgE levels to grass pollen allergens and Api g 1 (p < 0.020, rho <-0.10). Female and male participants showed no difference for BMI-for-age percentiles. In the pairwise comparison of ISAC score sum and categories of BMI-for-age percentiles, higher but not significantly different values were observed for participants <5th percentile compared to those in the 5th to 85th percentile (p = 0.061). However, a statistically significant difference was found between adolescents <5th percentile and those ≥85th percentile (p = 0.046; Fig. 1b). Significant differences among BMI-for-age percentile groups were observed for sensitization to Phl p 1, 4, 12, and profilins (p < 0.040).

Fig. 1

Study population, BMI-for-age percentiles, and influence of allergic family history. a Personal data of the adolescent study cohort. b BMI-for-age percentiles according to Barlow [32] and ISAC score sums. Lines indicate the median with interquartile ranges; dots represent the ISAC score sums of individual participants. c Association of IgE sensitization of the study participants versus existing allergies among family members is given as the odds ratio with 95% confidence interval.

Fig. 1

Study population, BMI-for-age percentiles, and influence of allergic family history. a Personal data of the adolescent study cohort. b BMI-for-age percentiles according to Barlow [32] and ISAC score sums. Lines indicate the median with interquartile ranges; dots represent the ISAC score sums of individual participants. c Association of IgE sensitization of the study participants versus existing allergies among family members is given as the odds ratio with 95% confidence interval.

Close modal

Family Size and Hereditary Allergy Predisposition

Eighty-nine percent of participants had at least 1 sibling and family sizes were between 3 and 6 individuals for 89.4% of the participants. No differences in IgE sensitization were found between only children and those with siblings, or with regard to family size. However, slightly negative correlations were observed between the number of siblings and IgE to PR-10 allergens (p < 0.0037, rho <-0.13). Subjects with at least 1 allergic family member (n = 245) had a sensitization prevalence of 59.6%, while those without (n = 222) showed a significantly lower atopy rate of 47.7% (p = 0.012) as well as ISAC score sum (p = 0.002). Interestingly, this also holds true when exclusively the father but not when only the mother was allergic (Fig. 1c).

Early Life Influences and Lifestyle Factors

Participants reported whether they had been vaccinated with standard vaccines, were born by caesarean section, and breastfed as infants. No differences between the respective groups in terms of IgE sensitization were observed. Participants who grew up on a farm showed a reduced sensitization rate of 45.5% (vs. 55.7% for those who did not grow up on farms), which was not statistically significant (p = 0.066). However, farm exposure resulted in a significantly reduced ISAC score sum (p = 0.004), and reduced IgE levels to PR-10 and grass pollen allergens (p < 0.007).

No difference in IgE sensitization was found with regard to alcohol consumption. Among the 46 female participants using hormonal contraceptives, no disparity in IgE sensitization was observed. In our study cohort, diet, exposure to passive smoke or air pollution, time spent outside, physical activity, stress, or sleep were not subjectively ranked differently between sensitized and nonsensitized individuals (Fig. 2). The number of participants reporting that they are smokers was rather low (n = 28), yet this translated into an increased sensitization rate (78.6%) and an increased odds ratio for being sensitized (p = 0.006, OR = 3.38). Also, the ISAC score sum (Fig. 3a) and ISU levels were significantly higher among smokers. The frequency of having a cold revealed a difference in ISAC score sum. Interestingly, individuals stating that they had never had a cold within the preceding 2 years, as well as those with the highest frequency (>6×) showed significantly decreased IgE levels compared to those who indicated that they had been affected 3-4 times (Fig. 3b).

Fig. 2

Lifestyle factors reported from nonsensitized (IgE-) and sensitized participants (IgE+). The boxes indicate the 25th to 75th percentile; horizontal lines indicate the median; whiskers indicate the 5th and 95th percentiles.

Fig. 2

Lifestyle factors reported from nonsensitized (IgE-) and sensitized participants (IgE+). The boxes indicate the 25th to 75th percentile; horizontal lines indicate the median; whiskers indicate the 5th and 95th percentiles.

Close modal
Fig. 3

Influence of smoking and having a cold. a Study participants were categorized into smokers and nonsmokers, and the respective ISAC score sum values are depicted. b The frequency of having a cold in the past 2 years (never to >6 times) plotted against the ISAC score sum.

Fig. 3

Influence of smoking and having a cold. a Study participants were categorized into smokers and nonsmokers, and the respective ISAC score sum values are depicted. b The frequency of having a cold in the past 2 years (never to >6 times) plotted against the ISAC score sum.

Close modal

As part of this study, the ISAC score sum was established to account for the number of sensitizations to single allergens and their ISU levels. Thus, a single value per subject was generated, allowing a more precise representation of the overall sensitization status compared to exclusive disjunction (yes/no judgement). In contrast to the evaluation of allergic symptoms, this study design allowed a detailed and specific measurement of IgE as a precursor of allergic diseases [9].

In line with previous studies [10,11,12,13], a higher sensitization frequency among male participants was noted. Interestingly, the preliminary data of Scala et al. [14] were confirmed, suggesting that male individuals have significantly higher IgE levels to profilin. The presented adolescent study cohort showed a trend towards gender discrepancies, which might become more pronounced with age as male IgE levels typically peak 10 years later [15]. We observed low correlations of female body height and ISAC score sum, as well as BMI-for-age percentiles and ISU values to predominately grass pollen allergens. An increased ISAC score sum for underweight participants was observed, which contrasts with the results from a Danish adult study, suggesting a decreased OR for IgE sensitization in underweight women but not men [12]. Other studies highlighted the relevance of an elevated body weight in childhood and increased allergy risk at a later stage [16,17,18]. While results indicate that body dimensions play a certain role in allergy, more detailed life-time analyses are needed. Analogous to previous studies, lower IgE levels were found among participants with more siblings [2,19]. While a hereditary component was clearly confirmed in our cohort [20,21,22], allergies of fathers, but not mothers, seemed to be the major confounding factor for IgE development in their offspring. Previous studies suggested that predominately maternal conditions play an important role in IgE production and asthma development in the offspring [23,24]. To the best of our knowledge, this represents the first study showing that paternal allergies represent the most important hereditary impact for IgE sensitization.

Early life influences, such as standard vaccines, caesarean delivery, and breastfeeding, did not significantly affect IgE sensitization in our cohort. These observations should, however, be noted with caution, since the number of individuals per group was unbalanced. The German MAS-90 study reported decreased sensitization rates in vaccinated children [25], while in our cohort the few individuals (n = 24) who were not vaccinated also demonstrated a sensitization rate >50%. Earlier studies, including higher numbers of participants born by cesarean, showed a significantly increased risk for atopy for this delivery mode [26]. A protective effect of breastfeeding on the development of allergic diseases has been suggested [27,28]. In our study, the majority of participants were breastfed, however this did not translate into lower IgE levels. As another study also reported no association between exclusive breastfeeding and sensitization until 7 years [29], the finding could be explained by the fact that breastfeeding does not necessarily confine IgE development, but rather shows a protective effect regarding clinical symptoms. However, it should also be kept in mind that the information regarding breastfeeding was self-reported by the subjects, with the associated limitations in accuracy. In line with the “hygiene hypothesis,” the beneficial effect of growing up on a farm was confirmed within this work [5,6,7]. The difference was particularly pronounced regarding sensitization to PR-10 and grass pollen allergens, which might relate to high pollen exposure among farm children and/or the general high sensitization rate towards these sources [8].

Among analyzed lifestyle aspects, only smoking showed a significant difference for IgE sensitization and frequently involved allergen molecules with very low sensitization rates [8]. An association of smoking and increased incidence of asthma and wheeze has been shown before [30], but an association between never smoking and a higher risk of atopy has also been reported [12,13]. Despite the low number of smokers, we found a statistically significant effect, emphasizing the negative impact of smoking already in this age group. Previous studies have shown an association between atopy and alcohol intake, and passive smoke exposure and sensitization to some allergen sources as well as time spent outdoors contributing to the development of allergies [2,12,20,31]. However, none of these factors caused statistically significant differences. Nevertheless, a trend was observed indicating that sensitized individuals spent more time outside, performed more sports, and reported poorer sleep than nonsensitized subjects. Participants stating to have a cold on a moderate basis had a significantly increased ISAC score sum compared to those that did not suffer from colds or individuals with a high frequency of episodes. This bimodal protection profile could be explained by a very robust immune system among those who very rarely experience a cold and have no allergies, or a favored Th1 response of the immune system among those frequently suffering from colds.

To conclude, this epidemiologic study investigated several intrinsic and environmental influences on the allergic sensitization of adolescents. IgE development could be linked to having an allergic father, not growing up in a farming environment, smoking, being underweight, and having a moderate frequency of colds.

This study was funded by Sparkling Science (www.sparklingscience.at), a program of the Federal Ministry of Science, Research and Economy of Austria (SPA 04/065-Alraune).

C. Wageneder-Schmid and the Biomedical Sciences team of the Salzburg University of Applied Sciences (K. Schwenoha, L. Helminger, J. Gmachl-Baumgartner, R. Wiltsche, U. Fötschl) are acknowledged for their support in this study. We thank the teachers E. Oberkofler (HBLA Ursprung), M. Hauer (BG Tamsweg), S. Fischinger (NMS Bürmoos), K. Schaffer (PdC BORG Radstadt), B. Wanzenböck (Musisches Gymnasium Salzburg), J. Pöttler (BG Seekirchen), R. Pilotto-Kofler and P. Paraschin-Wolfsberger (PG St. Rupert), M. Anderluch (BHAK/BHAS I Salzburg), G. Mussill and L. Mackner-Rath (BORG Nonntal), and the students of the participating schools for supporting the project.

G.G. received lecture fees from Thermo Fisher Scientific. All other authors declare no conflicts of interest.

1.
Akdis CA, Agache I (eds): Global Atlas of Allergy. Zurich, European Academy of Allergy and Clinical Immunology 2014.
2.
Kramer U, Oppermann H, Ranft U, Schafer T, Ring J, Behrendt H: Differences in allergy trends between East and West Germany and possible explanations. Clin Exp Allergy 2010;40:289-298.
3.
Matricardi PM, Kleine-Tebbe J, Hoffmann HJ, et al: EAACI molecular allergology user's guide. Pediatr Allergy Immunol 2016; 27(suppl 23):1-250.
4.
Rosenwasser LJ: Genetics of asthma and atopy. Toxicol Lett 1996;86:73-77.
5.
Braun-Fahrlander C, Gassner M, Grize L, Neu U, Sennhauser FH, Varonier HS, Vuille JC, Wuthrich B: Prevalence of hay fever and allergic sensitization in farmer's children and their peers living in the same rural community. SCARPOL team. Swiss Study on Childhood Allergy and Respiratory Symptoms with Respect to Air Pollution. Clin Exp Allergy 1999;29:28-34.
6.
Riedler J, Eder W, Oberfeld G, Schreuer M: Austrian children living on a farm have less hay fever, asthma and allergic sensitization. Clin Exp Allergy 2000;30:194-200.
7.
von Mutius E, Vercelli D: Farm living: effects on childhood asthma and allergy. Nat Rev Immunol 2010;10:861-868.
8.
Stemeseder T, Klinglmayr E, Moser S, Lueftenegger L, Lang R, Himly M, Oostingh GJ, Zumbach J, Bathke AC, Hawranek T, Gadermaier G: Cross-sectional study on allergic sensitization of Austrian adolescents using molecule-based IgE profiling. Allergy 2017;72:754-763.
9.
Hatzler L, Panetta V, Lau S, Wagner P, Bergmann RL, Illi S, Bergmann KE, Keil T, Hofmaier S, Rohrbach A, Bauer CP, Hoffman U, Forster J, Zepp F, Schuster A, Wahn U, Matricardi PM: Molecular spreading and predictive value of preclinical IgE response to Phleum pratense in children with hay fever. J Allergy Clin Immunol 2012;130:894-901.e895.
10.
Schmitz R, Ellert U, Kalcklosch M, Dahm S, Thamm M: Patterns of sensitization to inhalant and food allergens - findings from the German Health Interview and Examination Survey for Children and Adolescents. Int Arch Allergy Immunol 2013;162:263-270.
11.
Riedler J, Gamper A, Eder W, Oberfeld G: Prevalence of bronchial hyperresponsiveness to 4.5% saline and its relation to asthma and allergy symptoms in Austrian children. Eur Respir J 1998;11:355-360.
12.
Skaaby T, Husemoen LL, Thuesen BH, Jorgensen T, Linneberg A: Lifestyle-related factors and atopy in seven Danish population-based studies from different time periods. PLoS One 2015;10:e0137406.
13.
Salo PM, Arbes SJ Jr, Jaramillo R, Calatroni A, Weir CH, Sever ML, Hoppin JA, Rose KM, Liu AH, Gergen PJ, Mitchell HE, Zeldin DC: Prevalence of allergic sensitization in the United States: results from the National Health and Nutrition Examination Survey (NHANES) 2005-2006. J Allergy Clin Immunol 2014;134:350-359.
14.
Scala E, Alessandri C, Palazzo P, Pomponi D, Liso M, Bernardi ML, Ferrara R, Zennaro D, Santoro M, Rasi C, Mari A: IgE recognition patterns of profilin, PR-10, and tropomyosin panallergens tested in 3,113 allergic patients by allergen microarray-based technology. PLoS One 2011;6:e24912.
15.
De Amici M, Ciprandi G: The age impact on serum total and allergen-specific IgE. Allergy Asthma Immunol Res 2013;5:170-174.
16.
Flexeder C, Thiering E, Bruske I, Koletzko S, Bauer CP, Wichmann HE, Mansmann U, von Berg A, Berdel D, Kramer U, Schaaf B, Lehmann I, Herbarth O, Heinrich J: Growth velocity during infancy and onset of asthma in school-aged children. Allergy 2012;67:257-264.
17.
Rzehak P, Wijga AH, Keil T, Eller E, Bindslev-Jensen C, Smit HA, Weyler J, Dom S, Sunyer J, Mendez M, Torrent M, Vall O, Bauer CP, Berdel D, Schaaf B, Chen CM, Bergstrom A, Fantini MP, Mommers M, Wahn U, Lau S, Heinrich J: Body mass index trajectory classes and incident asthma in childhood: results from 8 European birth cohorts - a Global Allergy and Asthma European Network initiative. J Allergy Clin Immunol 2013;131:1528-1536.
18.
Byberg KK, Eide GE, Forman MR, Juliusson PB, Oymar K: Body mass index and physical activity in early childhood are associated with atopic sensitization, atopic dermatitis and asthma in later childhood. Clin Transl Allergy 2016;6:33.
19.
Svanes C, Jarvis D, Chinn S, Burney P: Childhood environment and adult atopy: results from the European Community Respiratory Health Survey. J Allergy Clin Immunol 1999;103:415-420.
20.
Enroth S, Dahlbom I, Hansson T, Johansson A, Gyllensten U: Prevalence and sensitization of atopic allergy and coeliac disease in the Northern Sweden Population Health Study. Int J Circumpolar Health 2013;72.
21.
Grabenhenrich LB, Gough H, Reich A, Eckers N, Zepp F, Nitsche O, Forster J, Schuster A, Schramm D, Bauer CP, Hoffmann U, Beschorner J, Wagner P, Bergmann R, Bergmann K, Matricardi PM, Wahn U, Lau S, Keil T: Early-life determinants of asthma from birth to age 20 years: a German birth cohort study. J Allergy Clin Immunol 2014;133:979-988.
22.
Grabenhenrich LB, Keil T, Reich A, Gough H, Beschorner J, Hoffmann U, Bauer CP, Forster J, Schuster A, Schramm D, Nitsche O, Zepp F, Lee YA, Bergmann R, Bergmann K, Wahn U, Lau S: Prediction and prevention of allergic rhinitis: a birth cohort study of 20 years. J Allergy Clin Immunol 2015;136:932-940.e912.
23.
Wu CC, Chen RF, Kuo HC: Different implications of paternal and maternal atopy for perinatal IgE production and asthma development. Clin Dev Immunol 2012;2012:132142.
24.
Canfield SM, Jacobson JS, Perzanowski MS, Mellins RB, Zemble RM, Chew GL, Goldstein IF: Total and specific IgE associations between New York City Head Start children and their parents. J Allergy Clin Immunol 2008;121:1422-1427.
25.
Gruber C, Illi S, Lau S, Nickel R, Forster J, Kamin W, Bauer CP, Wahn V, Wahn U: Transient suppression of atopy in early childhood is associated with high vaccination coverage. Pediatrics 2003;111:e282-e288.
26.
Kolokotroni O, Middleton N, Gavatha M, Lamnisos D, Priftis KN, Yiallouros PK: Asthma and atopy in children born by caesarean section: effect modification by family history of allergies - a population based cross-sectional study. BMC Pediatr 2012;12:179.
27.
Prescott S, Nowak-Wegrzyn A: Strategies to prevent or reduce allergic disease. Ann Nutr Metab 2011;59(suppl 1):28-42.
28.
Huang C, Liu W, Cai J, Weschler LB, Wang X, Hu Y, Zou Z, Shen L, Sundell J: Breastfeeding and timing of first dietary introduction in relation to childhood asthma, allergies, and airway diseases: a cross-sectional study. J Asthma 2016, Epub ahead of print.
29.
Jelding-Dannemand E, Malby Schoos AM, Bisgaard H: Breast-feeding does not protect against allergic sensitization in early childhood and allergy-associated disease at age 7 years. J Allergy Clin Immunol 2015;136:1302-1308.
30.
Genuneit J, Weinmayr G, Radon K, Dressel H, Windstetter D, Rzehak P, Vogelberg C, Leupold W, Nowak D, von Mutius E, Weiland SK: Smoking and the incidence of asthma during adolescence: results of a large cohort study in Germany. Thorax 2006;61:572-578.
31.
Yao TC, Chang SW, Hua MC, Liao SL, Tsai MH, Lai SH, Tseng YL, Yeh KW, Tsai HJ, Huang JL: Tobacco smoke exposure and multiplexed immunoglobulin E sensitization in children: a population-based study. Allergy 2016;71:90-98.
32.
Barlow SE: Expert committee recommendations regarding the prevention, assessment, and treatment of child and adolescent overweight and obesity: summary report. Pediatrics 2007;120:S164-S192.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.